Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Changes over time in Uric Acid in relation to Changes in Insulin Sensitivity, Beta-cell Function, and Glycemia.

Volpe A, Ye C, Hanley AJ, Connelly PW, Zinman B, Retnakaran R.

J Clin Endocrinol Metab. 2019 Nov 13. pii: dgz199. doi: 10.1210/clinem/dgz199. [Epub ahead of print]

PMID:
31720687
2.

The macrophage activation marker soluble CD163 is longitudinally associated with insulin sensitivity and β-cell function.

Semnani-Azad Z, Connelly PW, Johnston LW, Retnakaran R, Harris SB, Zinman B, Hanley AJ.

J Clin Endocrinol Metab. 2019 Nov 1. pii: dgz166. doi: 10.1210/clinem/dgz166. [Epub ahead of print]

PMID:
31677389
3.

Screening Glucose Challenge Test in Pregnancy Can Identify Women With an Adverse Postpartum Cardiovascular Risk Factor Profile: Implications for Cardiovascular Risk Reduction.

Retnakaran R, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B.

J Am Heart Assoc. 2019 Nov 5;8(21):e014231. doi: 10.1161/JAHA.119.014231. Epub 2019 Oct 28.

4.

Serum Ferritin and Glucose Homeostasis in Women With Recent Gestational Diabetes.

Hershenfeld S, Ye C, Hanley AJ, Connelly PW, Zinman B, Retnakaran R.

Can J Diabetes. 2019 Jun 21. pii: S1499-2671(19)30134-0. doi: 10.1016/j.jcjd.2019.06.003. [Epub ahead of print]

PMID:
31439472
5.

The Distribution of Fatty Acid Biomarkers of Dairy Intake across Serum Lipid Fractions: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort.

Santaren ID, Bazinet RP, Liu Z, Johnston LW, Sievenpiper JL, Giacca A, Retnakaran R, Harris SB, Zinman B, Hanley AJ.

Lipids. 2019 Oct;54(10):617-627. doi: 10.1002/lipd.12185. Epub 2019 Aug 19.

PMID:
31429083
6.

Serum apoA1 (Apolipoprotein A-1), Insulin Resistance, and the Risk of Gestational Diabetes Mellitus in Human Pregnancy-Brief Report.

Retnakaran R, Ye C, Connelly PW, Hanley AJ, Sermer M, Zinman B.

Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):2192-2197. doi: 10.1161/ATVBAHA.119.313195. Epub 2019 Aug 15.

PMID:
31412738
7.

INTERMITTENT INTENSIVE INSULIN THERAPY FOR TYPE 2 DIABETES: EFFECTS ON HYPOGLYCEMIA, WEIGHT GAIN, AND QUALITY OF LIFE OVER 2 YEARS.

Emery A, Ye C, Choi H, Kramer CK, Zinman B, Retnakaran R.

Endocr Pract. 2019 Sep;25(9):899-907. doi: 10.4158/EP-2019-0111. Epub 2019 Jun 6.

PMID:
31170361
8.

Glucose screening in pregnancy and future risk of cardiovascular disease in women: a retrospective, population-based cohort study.

Retnakaran R, Shah BR.

Lancet Diabetes Endocrinol. 2019 May;7(5):378-384. doi: 10.1016/S2213-8587(19)30077-4. Epub 2019 Mar 27.

PMID:
30928459
9.

Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis.

Kramer CK, Campbell S, Retnakaran R.

Diabetologia. 2019 Jun;62(6):905-914. doi: 10.1007/s00125-019-4840-2. Epub 2019 Mar 7. Review.

PMID:
30843102
10.

Stability of insulin and C-peptide measurement with long-term frozen storage of serum: Implications for diabetes research studies.

Retnakaran R, Ye C, Kramer CK.

Diabetes Obes Metab. 2018 Dec 18. doi: 10.1111/dom.13617. [Epub ahead of print]

PMID:
30565366
11.

Predicting and understanding the response to short-term intensive insulin therapy in people with early type 2 diabetes.

Nunez Lopez YO, Retnakaran R, Zinman B, Pratley RE, Seyhan AA.

Mol Metab. 2019 Feb;20:63-78. doi: 10.1016/j.molmet.2018.11.003. Epub 2018 Nov 16.

12.

Reply: Applying Network Meta-Analysis to Cardiovascular Outcome Trials of Glucose-Lowering Drugs.

Kramer CK, Ye C, Retnakaran R.

JACC Heart Fail. 2018 Dec;6(12):1052-1053. doi: 10.1016/j.jchf.2018.10.002. No abstract available.

PMID:
30497650
13.

Gestational diabetes in young women predicts future risk of serious liver disease.

Retnakaran R, Luo J, Shah BR.

Diabetologia. 2019 Feb;62(2):306-310. doi: 10.1007/s00125-018-4775-z. Epub 2018 Nov 13.

PMID:
30426169
14.

Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes.

Mehmood S, Ye C, Connelly PW, Hanley AJ, Zinman B, Retnakaran R.

Cardiovasc Diabetol. 2018 Oct 9;17(1):133. doi: 10.1186/s12933-018-0776-y.

15.

Hepatic fat and glucose tolerance in women with recent gestational diabetes.

Mehmood S, Margolis M, Ye C, Maple-Brown L, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R.

BMJ Open Diabetes Res Care. 2018 Sep 8;6(1):e000549. doi: 10.1136/bmjdrc-2018-000549. eCollection 2018.

16.

Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes: A Network Meta-Analysis.

Kramer CK, Ye C, Campbell S, Retnakaran R.

JACC Heart Fail. 2018 Oct;6(10):823-830. doi: 10.1016/j.jchf.2018.05.021. Epub 2018 Sep 5.

17.

Impact of daily incremental change in environmental temperature on beta cell function and the risk of gestational diabetes in pregnant women.

Retnakaran R, Ye C, Kramer CK, Hanley AJ, Connelly PW, Sermer M, Zinman B.

Diabetologia. 2018 Dec;61(12):2633-2642. doi: 10.1007/s00125-018-4710-3. Epub 2018 Aug 15.

PMID:
30112689
18.

Hyperglycaemia in pregnancy and the effect of diabetes on cardiovascular risk.

Retnakaran R, Sriram U, Wijeyaratne CN, Hod M, Kapur A.

Lancet Diabetes Endocrinol. 2018 Aug;6(8):599. doi: 10.1016/S2213-8587(18)30208-0. No abstract available.

PMID:
30053982
19.

Clusters of fatty acids in the serum triacylglyceride fraction associate with the disorders of type 2 diabetes.

Johnston LW, Liu Z, Retnakaran R, Zinman B, Giacca A, Harris SB, Bazinet RP, Hanley AJ.

J Lipid Res. 2018 Sep;59(9):1751-1762. doi: 10.1194/jlr.P084970. Epub 2018 Jul 9.

20.

Changes Over Time in Hepatic Markers Predict Changes in Insulin Sensitivity, β-Cell Function, and Glycemia.

Pinnaduwage L, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2651-2659. doi: 10.1210/jc.2018-00306.

PMID:
29897453
21.

Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancy.

Bajaj HS, Ye C, Hanley AJ, Sermer M, Zinman B, Retnakaran R.

Diab Vasc Dis Res. 2018 Sep;15(5):449-457. doi: 10.1177/1479164118779924. Epub 2018 Jun 5.

PMID:
29871496
22.

Early Weight Gain in Pregnancy and Infant Birth Weight-Reply.

Retnakaran R, Wen SW, Tan H.

JAMA Pediatr. 2018 Jun 1;172(6):598-599. doi: 10.1001/jamapediatrics.2018.0410. No abstract available.

PMID:
29710113
23.

Hyperglycemia in pregnancy and its implications for a woman's future risk of cardiovascular disease.

Retnakaran R.

Diabetes Res Clin Pract. 2018 Nov;145:193-199. doi: 10.1016/j.diabres.2018.04.008. Epub 2018 Apr 19. Review.

PMID:
29679623
24.

Effect of short-term intensive insulin therapy on the incretin response in early type 2 diabetes.

Choi H, Kramer CK, Zinman B, Connelly PW, Retnakaran R.

Diabetes Metab. 2019 Apr;45(2):197-200. doi: 10.1016/j.diabet.2018.01.003. Epub 2018 Jan 11.

PMID:
29395808
25.

Two-year trial of intermittent insulin therapy vs metformin for the preservation of β-cell function after initial short-term intensive insulin induction in early type 2 diabetes.

Retnakaran R, Choi H, Ye C, Kramer CK, Zinman B.

Diabetes Obes Metab. 2018 Jun;20(6):1399-1407. doi: 10.1111/dom.13236. Epub 2018 Feb 23.

PMID:
29377408
26.
27.

Novel Biomarkers for Predicting Cardiovascular Disease in Patients With Diabetes.

Retnakaran R.

Can J Cardiol. 2018 May;34(5):624-631. doi: 10.1016/j.cjca.2017.10.017. Epub 2017 Oct 31. Review.

PMID:
29287943
28.

Association of Timing of Weight Gain in Pregnancy With Infant Birth Weight.

Retnakaran R, Wen SW, Tan H, Zhou S, Ye C, Shen M, Smith GN, Walker MC.

JAMA Pediatr. 2018 Feb 1;172(2):136-142. doi: 10.1001/jamapediatrics.2017.4016.

29.

Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort.

Johnston LW, Harris SB, Retnakaran R, Giacca A, Liu Z, Bazinet RP, Hanley AJ.

Diabetologia. 2018 Apr;61(4):821-830. doi: 10.1007/s00125-017-4534-6. Epub 2017 Dec 24.

PMID:
29275428
30.

Effect of chronic liraglutide therapy and its withdrawal on time to postchallenge peak glucose in type 2 diabetes.

Tran S, Kramer CK, Zinman B, Choi H, Retnakaran R.

Am J Physiol Endocrinol Metab. 2018 Mar 1;314(3):E287-E295. doi: 10.1152/ajpendo.00374.2017. Epub 2017 Nov 28.

31.

Circulating B-type natriuretic peptide in women with and without recent gestational diabetes: The impact of current glucose intolerance.

De Souza LR, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R.

Clin Endocrinol (Oxf). 2018 Feb;88(2):227-233. doi: 10.1111/cen.13510. Epub 2017 Nov 27.

PMID:
29112786
32.

Maternal pre-gravid cardiometabolic health and infant birthweight: A prospective pre-conception cohort study.

Retnakaran R, Wen SW, Tan H, Zhou S, Ye C, Shen M, Smith GN, Walker MC.

Nutr Metab Cardiovasc Dis. 2017 Aug;27(8):723-730. doi: 10.1016/j.numecd.2017.05.005. Epub 2017 May 23.

PMID:
28693965
33.

Response to Pre-Pregnancy Blood Pressure and Offspring Sex in the HUNT Study, Norway.

Retnakaran R, Wen SW, Tan H, Zhou S, Ye C, Shen M, Smith GN, Walker MC.

Am J Hypertens. 2017 Sep 1;30(9):e9. doi: 10.1093/ajh/hpx107. No abstract available.

PMID:
28633294
34.

Impact of Changes Over Time in Adipokines and Inflammatory Proteins on Changes in Insulin Sensitivity, β-Cell Function, and Glycemia in Women With Previous Gestational Dysglycemia.

Retnakaran R, Ye C, Connelly PW, Hanley AJ, Sermer M, Zinman B.

Diabetes Care. 2017 Aug;40(8):e101-e102. doi: 10.2337/dc17-0781. Epub 2017 Jun 14. No abstract available.

PMID:
28615242
35.

Pre-gravid predictors of new onset hypertension in pregnancy - Results from a pre-conception cohort study in China.

Wen SW, Tan H, Retnakaran R, Shen M, Zhou S, Xie RH, Smith GN, Davidge ST, Trasler J, Walker MC.

Eur J Obstet Gynecol Reprod Biol. 2017 Jul;214:140-144. doi: 10.1016/j.ejogrb.2017.05.008. Epub 2017 May 12. No abstract available.

PMID:
28528249
36.

Adiponectin and β-Cell Adaptation in Pregnancy.

Retnakaran R.

Diabetes. 2017 May;66(5):1121-1122. doi: 10.2337/dbi17-0001. No abstract available.

37.

Impact of the Glucagon Assay When Assessing the Effect of Chronic Liraglutide Therapy on Glucagon Secretion.

Kramer CK, Zinman B, Choi H, Connelly PW, Retnakaran R.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2729-2733. doi: 10.1210/jc.2017-00928.

PMID:
28472325
38.

Asymmetric dimethylarginine and arginine metabolites in women with and without a history of gestational diabetes.

Arya S, Ye C, Connelly PW, Hanley AJ, Sermer M, Zinman B, Retnakaran R.

J Diabetes Complications. 2017 Jun;31(6):964-970. doi: 10.1016/j.jdiacomp.2017.03.009. Epub 2017 Mar 28.

PMID:
28392044
39.

Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes.

Kramer CK, Zinman B, Choi H, Connelly PW, Retnakaran R.

Diabetes Obes Metab. 2017 May;19(5):744-748. doi: 10.1111/dom.12858. Epub 2017 Feb 9.

PMID:
28181363
40.

Maternal Blood Pressure Before Pregnancy and Sex of the Baby: A Prospective Preconception Cohort Study.

Retnakaran R, Wen SW, Tan H, Zhou S, Ye C, Shen M, Smith GN, Walker MC.

Am J Hypertens. 2017 Apr 1;30(4):382-388. doi: 10.1093/ajh/hpw165.

PMID:
28057630
41.

Prior lactation reduces future diabetic risk through sustained postweaning effects on insulin sensitivity.

Bajaj H, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R.

Am J Physiol Endocrinol Metab. 2017 Mar 1;312(3):E215-E223. doi: 10.1152/ajpendo.00403.2016. Epub 2016 Dec 13.

42.

The Insulin-Like Growth Factor Axis: A New Player in Gestational Diabetes Mellitus?

Retnakaran R.

Diabetes. 2016 Nov;65(11):3246-3248. No abstract available.

43.

Role of Type 2 Diabetes in Determining Retinal, Renal, and Cardiovascular Outcomes in Women With Previous Gestational Diabetes Mellitus.

Retnakaran R, Shah BR.

Diabetes Care. 2017 Jan;40(1):101-108. doi: 10.2337/dc16-1400. Epub 2016 Nov 7.

PMID:
27821407
44.

Hepatic fat and abdominal adiposity in early pregnancy together predict impaired glucose homeostasis in mid-pregnancy.

De Souza LR, Berger H, Retnakaran R, Vlachou PA, Maguire JL, Nathens AB, Connelly PW, Ray JG.

Nutr Diabetes. 2016 Sep 19;6(9):e229. doi: 10.1038/nutd.2016.39.

45.

Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes.

Kramer CK, Zinman B, Choi H, Retnakaran R.

BMJ Open Diabetes Res Care. 2016 Aug 1;4(1):e000270. doi: 10.1136/bmjdrc-2016-000270. eCollection 2016.

46.

Fetal sex and maternal risk of pre-eclampsia/eclampsia: a systematic review and meta-analysis.

Jaskolka D, Retnakaran R, Zinman B, Kramer CK.

BJOG. 2017 Mar;124(4):553-560. doi: 10.1111/1471-0528.14163. Epub 2016 Jun 17. Review.

47.

Impact of Twin Gestation and Fetal Sex on Maternal Risk of Diabetes During and After Pregnancy.

Retnakaran R, Shah BR.

Diabetes Care. 2016 Aug;39(8):e110-1. doi: 10.2337/dc16-0825. Epub 2016 May 23. No abstract available.

PMID:
27222507
48.

Maternal Serum Prolactin and Prediction of Postpartum β-Cell Function and Risk of Prediabetes/Diabetes.

Retnakaran R, Ye C, Kramer CK, Connelly PW, Hanley AJ, Sermer M, Zinman B.

Diabetes Care. 2016 Jul;39(7):1250-8. doi: 10.2337/dc16-0043. Epub 2016 Apr 26.

PMID:
27208323
49.

Serum Folate Shows an Inverse Association with Blood Pressure in a Cohort of Chinese Women of Childbearing Age: A Cross-Sectional Study.

Shen M, Tan H, Zhou S, Retnakaran R, Smith GN, Davidge ST, Trasler J, Walker MC, Wen SW.

PLoS One. 2016 May 16;11(5):e0155801. doi: 10.1371/journal.pone.0155801. eCollection 2016.

50.

Longitudinal Associations of Phospholipid and Cholesteryl Ester Fatty Acids With Disorders Underlying Diabetes.

Johnston LW, Harris SB, Retnakaran R, Zinman B, Giacca A, Liu Z, Bazinet RP, Hanley AJ.

J Clin Endocrinol Metab. 2016 Jun;101(6):2536-44. doi: 10.1210/jc.2015-4267. Epub 2016 May 4.

PMID:
27144932

Supplemental Content

Loading ...
Support Center